BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20567154)

  • 1. Lymphatic vessel density as a prognostic marker in clinical stage I endocervical adenocarcinoma.
    Saad RS; Ismiil N; Ghorab Z; Nofech-Mozes S; Dubé V; Covens A; Khalifa MA
    Int J Gynecol Pathol; 2010 Jul; 29(4):386-93. PubMed ID: 20567154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic vessel density as prognostic marker in esophageal adenocarcinoma.
    Saad RS; Lindner JL; Liu Y; Silverman JF
    Am J Clin Pathol; 2009 Jan; 131(1):92-8. PubMed ID: 19095571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas.
    El-Gohary YM; Metwally G; Saad RS; Robinson MJ; Mesko T; Poppiti RJ
    Am J Clin Pathol; 2008 Apr; 129(4):578-86. PubMed ID: 18343785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritumoral lymphatic microvessel density associated with tumor progression and poor prognosis in gastric carcinoma.
    Coşkun U; Akyürek N; Dursun A; Yamaç D
    J Surg Res; 2010 Nov; 164(1):110-5. PubMed ID: 19628230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritumoral lymphatic vessel density as a prognostic parameter in endometrial carcinoma: an immunohistochemical study.
    Maghraby HK; Elsarha AI; Saad RS
    Indian J Pathol Microbiol; 2010; 53(3):465-9. PubMed ID: 20699504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of peritumoral lymphatic vessel density and lymphatic vessel invasion detected by D2-40 immunostaining in FIGO Ib1-IIa squamous cell cervical cancer.
    Xiong Y; Cao LP; Rao HL; Cai MY; Liang LZ; Liu JH
    Cell Tissue Res; 2012 Jun; 348(3):515-22. PubMed ID: 22492093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.
    Gombos Z; Xu X; Chu CS; Zhang PJ; Acs G
    Clin Cancer Res; 2005 Dec; 11(23):8364-71. PubMed ID: 16322297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aggressiveness of urothelial carcinoma depends to a large extent on lymphovascular invasion--the prognostic contribution of related molecular markers.
    Afonso J; Santos LL; Amaro T; Lobo F; Longatto-Filho A
    Histopathology; 2009 Nov; 55(5):514-24. PubMed ID: 19912357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral but not peritumoral lymphatic vessel density measured by D2-40 expression predicts poor outcome in gastric cancer--ROC curve analysis to find cut-off point.
    Donizy P; Rudno-Rudzinska J; Halon A; Dziegala M; Kabarowski J; Frejlich E; Dziegiel P; Kielan W; Matkowski R
    Anticancer Res; 2014 Jun; 34(6):3113-8. PubMed ID: 24922680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma.
    Ma Y; Hou Y; Liu B; Li X; Yang S; Ma J
    Anat Rec (Hoboken); 2010 Nov; 293(11):1847-54. PubMed ID: 20730866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
    Adachi Y; Nakamura H; Kitamura Y; Taniguchi Y; Araki K; Shomori K; Horie Y; Kurozawa Y; Ito H; Hayashi K
    Pathol Int; 2007 Apr; 57(4):171-7. PubMed ID: 17316411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.
    Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H
    Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic vessel densities of lymph node-negative prostate adenocarcinoma in Korea.
    Kim HS; Sung W; Lee S; Chang SG; Park YK
    Pathol Res Pract; 2009; 205(4):249-54. PubMed ID: 19058917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Lymphatic Vessel Density Detected by D2-40 and Its Relation to Claudin-4 Expression in Prostatic Adenocarcinoma.
    Radi DA; Abd-Elazeem MA
    Int J Surg Pathol; 2016 May; 24(3):219-26. PubMed ID: 26464161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic spread in squamous cell carcinoma of the penis is independent of elevated lymph vessel density.
    Naumann CM; Al-Najar A; Alkatout I; Hegele A; Korda JB; Bolenz C; Kalthoff H; Sipos B; Juenemann KP; van der Horst C
    BJU Int; 2009 Jun; 103(12):1655-9; discussion 1659. PubMed ID: 19220258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased intratumoral lymphatic vessel density correlates with lymph node metastasis in early gastric carcinoma.
    Lee K; Park DJ; Choe G; Kim HH; Kim WH; Lee HS
    Ann Surg Oncol; 2010 Jan; 17(1):73-80. PubMed ID: 19777179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of periductal lymphatic and blood vascular densities in intraductal carcinoma of the breast.
    El-Gohary YM; Metwally G; Saad RS; Robinson MJ; Mesko T; Poppiti RJ
    Breast J; 2009; 15(3):261-7. PubMed ID: 19645781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic vessel density and lymph node metastasis in prostate cancer.
    Zeng Y; Opeskin K; Horvath LG; Sutherland RL; Williams ED
    Prostate; 2005 Nov; 65(3):222-30. PubMed ID: 15948136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of lymphatic invasion in early stage primary colorectal cancer with the monoclonal antibody D2-40.
    Walgenbach-Bruenagel G; Tolba RH; Varnai AD; Bollmann M; Hirner A; Walgenbach KJ
    Eur Surg Res; 2006; 38(5):438-44. PubMed ID: 16912482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic vessel invasion detected by the D2-40 monoclonal antibody is an independent prognostic factor in node-negative esophageal squamous cell carcinoma.
    Imamura Y; Watanabe M; Nagai Y; Baba Y; Hirashima K; Karashima R; Iwatsuki M; Yoshida N; Kinoshita K; Kurashige J; Iyama K; Baba H
    J Surg Oncol; 2012 Mar; 105(3):277-83. PubMed ID: 22271500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.